Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1874]
News [4299]
Articles [404]
Editorials [10]
Conferences [107]
elearning [41]
Treating BRCA breast cancer with PARP inhibition
Dr Mika Sovak - AstraZeneca, Cambridge, UK
Treating BRCA breast cancer with PARP inhibition ( Dr Mika Sovak - AstraZeneca, Cambridge, UK )
4 Jun 2017
Phase III results of olaparib for BRCA breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Phase III results of olaparib for BRCA breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy
Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy ( Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy )
4 Jun 2017
Olaparib slows growth of BRCA-related metastatic breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Olaparib slows growth of BRCA-related metastatic breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
No link between pregnancy and breast cancer relapse
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
No link between pregnancy and breast cancer relapse ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
4 Jun 2017
Pregnancy after breast cancer no associated with relapse risk
Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium
Pregnancy after breast cancer no associated with relapse risk ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )
3 Jun 2017
Functions of BRCA1 and the implications for treatment
Dr Jo Morris - University of Birmingham, Birmingham, UK
Functions of BRCA1 and the implications for treatment ( Dr Jo Morris - University of Birmingham, Birmingham, UK )
15 May 2017
Genetic determinants of breast cancer immune phenotypes
Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
Genetic determinants of breast cancer immune phenotypes ( Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
12 May 2017
IMPAKT conference highlights
Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
IMPAKT conference highlights ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
12 May 2017
Mutational landscapes in pregnant and non-pregnant breast cancer
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Mutational landscapes in pregnant and non-pregnant breast cancer ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
12 May 2017
Resistance to CDK4/6 inhibitors
Dr Nicholas Turner - The Institute of Cancer Research, London, UK
Resistance to CDK4/6 inhibitors ( Dr Nicholas Turner - The Institute of Cancer Research, London, UK )
12 May 2017
Deciphering the connection of genetics, immune infiltration and prognosis
Dr Jan Budczies - Charité Universitätsmedizin Berlin, Berlin, Germany
Deciphering the connection of genetics, immune infiltration and prognosis ( Dr Jan Budczies - Charité Universitätsmedizin Berlin, Berlin, Germany )
12 May 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation